Innovis Asset Management LLC Iovance Biotherapeutics, Inc. Transaction History

Innovis Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$5.36 - $9.06 $686 - $1,159	128 Added 0.49%	26,512 $187 Million
Q1 2023 May 10, 2023	SELL	$5.53 - $8.22 $80,726 - $119,995	-14,598 Reduced 35.62%	26,384 $161 Million
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $230,318 - $409,820	40,982 New	40,982 $262 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.24B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Innovis Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Innovis Asset Management LLC with notifications on news.